Résultats de la recherche - 124 results

challenges. This case study offers insights into the development of a highly sensitive linkage between COVID-19 hospital data and information related to social and health use in Belgium. Methods The HELICON ...

a relatively high morbidity burden. • Information on psoriasis prevalence and burden are crucial for disease management and appropriate health-care planning. Health Topics:  Chronic disease Maladie chronique ...

Publication Type: Scientific poster, presentation or proceeding Authors: Rafiqa Benchrih; Buekers, J; Claire Demoury; Martins, C; Purece, A; Thomsen, S T; Nadia Waegeneers; Eva M De Clercq; Brecht Devleesschauwer Source: European Journal of Public Health, ...

intervention focused mainly on the main challenges related to rare diseases, in particular diagnostic wandering, as well as the importance of making these diseases more visible in the hospital environment, ...

This presentation will focus on the experience from the DRUGPREP project. While foresight has been used in other sectors, its implementation in the drugs field has previously remained relatively limited. ...

enable the iterative and flexible monitoring of Belgian policies related to the EBCP ’s implementation, while generating buy-in from stakeholders. To achieve this goal, a modified Delphi process was used, ...

relating to PAP. Secondly, a cross-sectional survey was conducted in Belgian GP s between January and March 2023 for which descriptive statistics were performed. Results In Belgium, there is no national ...

Publication Type: Scientific poster, presentation or proceeding Authors: V. De Prez Source: OECD Directorate for employment, labour and social affairs health committee, OECD, Paris, France (2024) Keywords: Health workforce well-being Full text language:  ...

Objective The aim of the Be.well.pro survey is to monitor work-related mental well-being of healthcare  and welfare professionals in Belgium. A first measurement in a national, representative sample will be ...

disguise the risks related to the unknowingly intake of API s should not be neglected. Next to the national action plan performed by the Federal Agency of Medicines and Health products in collaboration with ...